Clinical Trials Logo

Filter by:
NCT ID: NCT05299814 Recruiting - ADHD Clinical Trials

Impact of Parental Emotion Regulation on the Treatment of ADHD

PERS
Start date: April 13, 2017
Phase: N/A
Study type: Interventional

Aim: To examine if parental emotion regulation (ER) moderates the response to parent training interventions. H1: Reduced parental ER capacity will predict diminished efficacy for behavioral parent training to improve negative parenting behavior (NPB) and behavior problems in offspring with ADHD. H2: Increased parental emotional reactivity will predict diminished efficacy for behavioral parent training to improve negative parenting behavior (NPB) and behavior problems in offspring with ADHD.

NCT ID: NCT03399344 Recruiting - Ovarian Cancer Clinical Trials

Clinical Impact of Dedicated MR Staging of Ovarian Cancer

MRStagingOC
Start date: April 13, 2018
Phase: N/A
Study type: Interventional

The only chance of cure for patients with advanced stage ovarian cancer is complete cytoreductive surgery (CRS). The only way to determine whether complete CRS can be achieved is by a laparoscopy. However, diffusion-weighted magnetic resonance imaging (DW-MRI) has a very high sensitivity to detect small volume malignant disease, making it a potentially suitable staging tool. Aim of this study is to determine the performance of DW-MRI for predicting whether complete CRS can be achieved.

NCT ID: NCT03404895 Recruiting - Diabetes Clinical Trials

The Mount Sinai Diabetic Foot Ulcer Prospective Trial

Start date: April 13, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether placing stent(s) for a blockage in a leg vein will help improve the healing of diabetic foot ulcers (DFU). The investigators know from having taken care of many patients with diabetic foot ulcers that it is a major cause of disability and amputation. These diabetic foot ulcers frequently heal slowly or not at all. They sometimes become infected and require antibiotic therapy, debridement and amputation. The investigators normally take care of a diabetic foot ulcer with a combination of local wound care, surgical debridement if necessary, antibiotics if there is an infection, and reduction of pressure on the area of the foot with the ulcer. The investigators observed that some patients with a diabetic foot ulcer also have a blockage in a major leg vein referred to as the iliac vein. This blockage in the iliac vein prevents the proper flow of blood from the leg. This blockage results in pressure within the leg veins leading to swelling in the legs which may also prevent healing of the diabetic foot ulcer. This study will investigate whether placing stent(s) to treat the blockage(s) will improve healing of the diabetic foot ulcer and reduce some of the complications associated with a diabetic foot ulcer. The results of this study could result in a new treatment that will allow future patients with diabetic foot ulcers to heal better. Right now, placing stents for these blockages in the iliac vein is not the standard of care treatment for a diabetic foot ulcer. In order for us to determine whether stent placement is helpful, the researchers will have to randomize each patient. In other words, to reduce bias, patients will be assigned either to a group receiving a stent or to a group not receiving a stent. Every patient in both groups will receive the standard of care for a diabetic foot ulcer and undergo an x-ray with contrast and intravenous ultrasound examination of the legs. The standard of care for a diabetic foot ulcer may include local wound care, antibiotic therapy, debridement and/or amputation, and pressure offloading in the foot.

NCT ID: NCT03496311 Recruiting - Pregnancy Clinical Trials

Cerebrospinal Acid-base in Pregnant and Non-pregnant Fertile Women

Start date: April 13, 2018
Phase:
Study type: Observational

The third trimester of pregnancy is typically characterized by the development of a marked respiratory alkalosis. The possible role of pregnancy-induced variations of cerebrospinal fluid (CSF) acid-base characteristics on the development of hypocapnic alkalosis is still unknown. Aim of this study is to characterize, according to Stewart's approach, the acid-base equilibrium of CSF and arterial plasma of pregnant women and compare the results with data obtained from fertile, non-pregnant women.

NCT ID: NCT03545555 Recruiting - Clinical trials for Effects of Kale Ingredients on Lipid Status Parameter

Investigations on the Effect of Kale on the Lipid Status

HypocholKale
Start date: April 13, 2018
Phase: N/A
Study type: Interventional

This intervention study investigates the effects of various kale preparations (dietary supplements) on lipid status parameters. Within the study period of 8 weeks, three blood withdrawals are planned (week 0, 4 and 8) for the volunteers. Lipid status parameters (total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides) will be determined in blood. There is a correlation between contents of LDL cholesterol, total cholesterol and triacylglycerides and the risk for cardiovascular diseases (CVD). In contrast, a high content of HDL cholesterol is correlated with a lower risk for CVD. In addition, the contents of apolipoprotein A1 and apolipoprotein B will be analysed.

NCT ID: NCT04128865 Recruiting - Cancer Clinical Trials

PRevention of INteractions Between Phytotherapies and CancEr Treatments by a SmartphonE/Tablet Automated SurvEy

PRINCESSE
Start date: April 13, 2018
Phase:
Study type: Observational

The use of phytotherapies or specific food or dietary supplement (HFDS) is common among cancer patients. They can also be responsible of clinically relevant interaction with anti-cancer treatments. This study aims at assessing the proportion patients using HFDS which are likely to have an interaction with their anticancer treatments. The data is collected through a smartphone/tablet application. The aim of the study is to demonstrate that clinically significant herb-drug interaction with anticancer treatment could be avoid using these devices.

NCT ID: NCT04272021 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children

MIMOSA
Start date: April 13, 2018
Phase: Phase 4
Study type: Interventional

MIMOSA study aims to characterize from behavioral, neurophysiological and neurocognitive perspectives children and adolescents with attention deficit hyperactivity disorder (ADHD), in order to identify a possible biomarker of response to medication treatments. To achieve this aim, in the study children with ADHD (drug naive) are recruited and undergo behavioral and clinical screenings, neurocognitive profile, and neurophysiological evaluation with functional near infrared spectroscopy (fNIRS). ADHD group is evaluated before the beginning of medications, at first dose of medication (only imaging evaluation fNIRS), and after a period of two/three months of continuous treatment with medication.

NCT ID: NCT03547830 Recruiting - Clinical trials for Chronic Granulomatous Disease

Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients

Start date: April 13, 2019
Phase: Phase 2
Study type: Interventional

Treatment Study to assess of safety and efficiency of conditioning with Plerixafor and G-CSF as additional agents for prevention of graft failure after transplantation in patients with chronic granulomatous disease

NCT ID: NCT03790527 Recruiting - Clinical trials for Internet Gaming Disorder

Cognitive Bias Modification Training on Internet Gaming Disorder

CBM&IGD
Start date: April 13, 2019
Phase: N/A
Study type: Interventional

To investigate whether and how the CBM training will alleviate the symptoms of addiction in Internet gaming disorders.

NCT ID: NCT03800199 Recruiting - Fibromyalgia Clinical Trials

The Validity and Reliability of the Turkish Version of the Combined Index of Severity of Fibromyalgia

Start date: April 13, 2019
Phase: N/A
Study type: Interventional

The aim of the investigator's study is to determine the validity and reliability of the Turkish version of the Combined Index of Severity (ICAF) in Turkish patients with Fibromyalgia Syndrome (FMS).